Reevaluation of the post-marketing safety of Shuxuening injection based on real-world and evidence-based evaluations
Can Wang,1,2 Qing-ping Shi,1,2 Feng Ding,2 Xiao-dong Jiang,1,2 Wei Tang,3 Mei-Ling Yu,1,2 Jian-Hua Zhu2 1Department of Pharmacy, The First Affiliated Hospital of Bengbu Medical College, Bengbu, People’s Republic of China; 2Faculty of Pharmacy, Bengbu Medical College, Bengbu, People&rs...
Main Authors: | Wang C, Shi QP, Ding F, Jiang XD, Tang W, Yu ML, Zhu JH |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-04-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/reevaluation-of-the-post-marketing-safety-of-shuxuening-injection-base-peer-reviewed-article-DDDT |
Similar Items
-
Recovery of post-stroke cognitive and motor deficiencies by Shuxuening injection via regulating hippocampal BDNF-mediated Neurotrophin/Trk Signaling
by: Zhixiong Li, et al.
Published: (2021-09-01) -
Peculiarities of Reevaluation Results Treatment Pertained to Grounds According to Their Destination
by: Andreea Elena Dreghiciu
Published: (2016-01-01) -
Effect of adjuvant Shuxuening injection therapy on the inflammatory response mediated by TLRs in patients with acute exacerbation of COPD
by: Jie Li, et al.
Published: (2017-04-01) -
Shuxuening injection facilitates neurofunctional recovery via down-regulation of G-CSF-mediated granulocyte adhesion and diapedesis pathway in a subacute stroke mouse model
by: Zhixiong Li, et al.
Published: (2020-07-01) -
Tnfrsf12a-Mediated Atherosclerosis Signaling and Inflammatory Response as a Common Protection Mechanism of Shuxuening Injection Against Both Myocardial and Cerebral Ischemia-Reperfusion Injuries
by: Ming Lyu, et al.
Published: (2018-04-01)